114 related articles for article (PubMed ID: 32436406)
1. Investigation of copeptin levels in foetal congenital central nervous system anomalies.
Çilgin H
J Obstet Gynaecol; 2021 Jan; 41(1):49-54. PubMed ID: 32436406
[TBL] [Abstract][Full Text] [Related]
2. First and third trimester serum concentrations of adropin and copeptin in gestational diabetes mellitus and normal pregnancy.
Dąbrowski FA; Jarmużek P; Gondek A; Cudnoch-Jędrzejewska A; Bomba-Opoń D; Wielgoś M
Ginekol Pol; 2016; 87(9):629-634. PubMed ID: 27723069
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia.
Birdir C; Janssen K; Stanescu AD; Enekwe A; Kasimir-Bauer S; Gellhaus A; Kimmig R; Köninger A
Arch Gynecol Obstet; 2015 Nov; 292(5):1033-42. PubMed ID: 25975456
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum copeptin concentrations in early- and late-onset pre-eclampsia.
Tuten A; Oncul M; Kucur M; Imamoglu M; Ekmekci OB; Acıkgoz AS; Cebe FS; Yesilbas C; Madazlı R
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):350-4. PubMed ID: 26384049
[TBL] [Abstract][Full Text] [Related]
5. The utility of pregnancy associated plasma protein-A MoM values in prediction of term respiratory distress syndrome.
Karaaslan O; Seckin KD; Kadirogullari P; Kiyak H; Bestel M; Simsek E; Aydin AA
J Obstet Gynaecol; 2020 Feb; 40(2):200-204. PubMed ID: 31347423
[TBL] [Abstract][Full Text] [Related]
6. PAPP-A concentrations change in patients with gestational diabetes.
Caliskan R; Atis A; Aydin Y; Acar D; Kiyak H; Topbas F
J Obstet Gynaecol; 2020 Feb; 40(2):190-194. PubMed ID: 31335241
[TBL] [Abstract][Full Text] [Related]
7. Maternal copeptin levels in intrahepatic cholestasis of pregnancy.
Tayyar A; Temel Yuksel I; Koroglu N; Tanay Tayyar A; Alici Davutoglu E; Akkaya Firat A; Aslan Cetin B
J Matern Fetal Neonatal Med; 2018 Aug; 31(15):2066-2070. PubMed ID: 28552021
[TBL] [Abstract][Full Text] [Related]
8. Copeptin is not a useful biomarker for small-for-gestational-age: a case control study.
Hansen AT; Sandager P; Uldbjerg N; Hvas AM
Scand J Clin Lab Invest; 2014 Nov; 74(8):687-92. PubMed ID: 25120188
[TBL] [Abstract][Full Text] [Related]
9. Ultrafast MR imaging of the foetus: a study of 25 non-central nervous system anomalies.
Dell'Acqua A; Mengozzi E; Rizzo F; Ciccone MA; Lituania M; De Biasio P; Venturini P; Tomà P
Radiol Med; 2002; 104(1-2):75-86. PubMed ID: 12386558
[TBL] [Abstract][Full Text] [Related]
10. Prediction of preeclampsia using combination of biomarkers at 18-23 weeks of gestation: A nested case-control study.
Jadli A; Ghosh K; Damania K; Satoskar P; Bansal V; Shetty S
Pregnancy Hypertens; 2019 Jul; 17():20-27. PubMed ID: 31487641
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of central nervous system abnormalities: comparison of prenatal neurosonography and foetal magnetic resonance imaging findings.
Demir SS; Cagliyan E; Sarioglu FC; Guleryuz H; Altunyurt S
J Obstet Gynaecol; 2022 Apr; 42(3):389-395. PubMed ID: 34238109
[TBL] [Abstract][Full Text] [Related]
12. Copeptin in Patients with Pregnancy-Induced Hypertension.
Marek A; Stojko R; Drosdzol-Cop A
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34203843
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the value of plasma concentration of copeptin in the first prenatal visit to diagnose gestational diabetes mellitus.
Ma HH; Yang SY; Wang P; Zhang JF
Acta Diabetol; 2017 Dec; 54(12):1123-1129. PubMed ID: 28980069
[TBL] [Abstract][Full Text] [Related]
14. Copeptin concentrations are not elevated in gestational diabetes mellitus.
Oncul M; Tuten A; Kucur M; Imamoglu M; Ekmekci OB; Acıkgoz AS; Madazlı R
Arch Gynecol Obstet; 2013 Nov; 288(5):1045-9. PubMed ID: 23677420
[TBL] [Abstract][Full Text] [Related]
15. Identification of patients at risk for preeclampsia with the use of uterine artery Doppler velocimetry and copeptin.
Yeşil A; Kanawati A; Helvacıoğlu Ç; Kaya C; Özgün ÇG; Cengiz H
J Matern Fetal Neonatal Med; 2017 Nov; 30(22):2763-2768. PubMed ID: 27868455
[TBL] [Abstract][Full Text] [Related]
16. Maternal first trimester serum levels of free-beta human chorionic gonadotrophin and male genital anomalies.
Schneuer FJ; Bower C; Holland AJ; Tasevski V; Jamieson SE; Barker A; Lee L; Majzoub JA; Nassar N
Hum Reprod; 2016 Aug; 31(8):1895-903. PubMed ID: 27496947
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of serum levels and reference ranges of copeptin in the 3rd trimester of pregnancy in healthy pregnant women with uncomplicated pregnancy and delivery.
Roubalová L; Gardlo A; Horejskova S; Dudova A; Krofta L; Ľubušký M
Ceska Gynekol; 2024; 89(2):89-94. PubMed ID: 38704219
[TBL] [Abstract][Full Text] [Related]
18. Foetal central nervous system anomalies: frequency and foeto-maternal outcome.
Amer N; Amer M; Kolkailah M; Al-Dumairy M
J Pak Med Assoc; 2014 Nov; 64(11):1282-6. PubMed ID: 25831647
[TBL] [Abstract][Full Text] [Related]
19. The Assessment of Copeptin and Brain Natriuretic Peptide Levels as Biomarkers in Hypertensive Disorders of Pregnancy.
Okwor CJ; Adedapo KS; Bello OO; Adedapo AD; Okwor VC
West Afr J Med; 2020; 37(3):231-236. PubMed ID: 32476116
[TBL] [Abstract][Full Text] [Related]
20. Fetal Neurosonogaphy: Ultrasound and Magnetic Resonance Imaging in Competition.
Tercanli S; Prüfer F
Ultraschall Med; 2016 Dec; 37(6):555-557. PubMed ID: 27978593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
